824 related articles for article (PubMed ID: 22464811)
1. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
[TBL] [Abstract][Full Text] [Related]
2. Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3).
Loras C; Gisbert JP; Saro MC; Piqueras M; Sánchez-Montes C; Barrio J; Ordás I; Montserrat A; Ferreiro R; Zabana Y; Chaparro M; Fernández-Bañares F; Esteve M;
J Crohns Colitis; 2014 Nov; 8(11):1529-38. PubMed ID: 25052345
[TBL] [Abstract][Full Text] [Related]
3. Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
Waszczuk E; Waszczuk KM; Mulak A; Paradowski L
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):628-32. PubMed ID: 26904976
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
[TBL] [Abstract][Full Text] [Related]
6. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
[TBL] [Abstract][Full Text] [Related]
8. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
Gibney KB; Torresi J; Lemoh C; Biggs BA
J Med Virol; 2008 Sep; 80(9):1565-9. PubMed ID: 18649341
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.
Chevaux JB; Nani A; Oussalah A; Venard V; Bensenane M; Belle A; Gueant JL; Bigard MA; Bronowicki JP; Peyrin-Biroulet L
Inflamm Bowel Dis; 2010 Jun; 16(6):916-24. PubMed ID: 19885908
[TBL] [Abstract][Full Text] [Related]
10. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area: inadequate protective antibody levels in young patients.
Kim ES; Cho KB; Park KS; Jang BI; Kim KO; Jeon SW; Kim EY; Yang CH; Kim WJ;
J Clin Gastroenterol; 2014 Jul; 48(6):553-8. PubMed ID: 24162170
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
13. The long-term effects of anti-TNF-α agents on patients with chronic viral hepatitis C and B infections.
Temel T; Cansu DÜ; Korkmaz C; Kaşifoğlu T; Özakyol A
Int J Rheum Dis; 2015 Jan; 18(1):40-5. PubMed ID: 25195983
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
[TBL] [Abstract][Full Text] [Related]
15. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
16. Outcome of patients with serology suggestive of past hepatitis B virus infection during antitumor necrosis factor therapy for psoriasis.
Navarro R; Concha-Garzón MJ; Castaño C; Casal C; Guiu A; Daudén E
Int J Dermatol; 2014 Jul; 53(7):909-11. PubMed ID: 24673290
[TBL] [Abstract][Full Text] [Related]
17. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
Chakravarti A; Verma V; Jain M; Kar P
Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
[TBL] [Abstract][Full Text] [Related]
19. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity.
Haushofer AC; Hauer R; Brunner H; Köller U; Trubert-Exinger D; Halbmayer WM; Koidl C; Kessler HH
J Clin Virol; 2004 Apr; 29(4):221-3. PubMed ID: 15018848
[TBL] [Abstract][Full Text] [Related]
20. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
Esteve M; Saro C; González-Huix F; Suarez F; Forné M; Viver JM
Gut; 2004 Sep; 53(9):1363-5. PubMed ID: 15306601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
